This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Carroll-Anzinger, D. Articles by Al-Harthi, L. Search for Related Content PubMed PubMed Citation Articles by Carroll-Anzinger, D. Articles by Al-Harthi, L.

 Previous Article  |  Next Article 

Journal of Virology, June 2007, p. 5864-5871, Vol. 81, No. 11
0022-538X/07/$08.00+0     doi:10.1128/JVI.02234-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Human Immunodeficiency Virus-Restricted Replication in Astrocytes and the Ability of Gamma Interferon To Modulate This Restriction Are Regulated by a Downstream Effector of the Wnt Signaling Pathway

Deborah Carroll-Anzinger,¹ Anvita Kumar,¹ Vyacheslav Adarichev,² Fatah Kashanchi,³ and Lena Al-Harthi^1*

Department of Immunology/Microbiology,¹ Section of Molecular Medicine, Department of Orthopedic Surgery, Rush University Medical Center, Chicago, Illinois 60612,² Department of Biochemistry and Molecular Biology, George Washington University, Washington, DC 20052³

Received 11 October 2006/ Accepted 9 March 2007

Astrocyte dysregulation correlates with the severity and the rate of human immunodeficiency virus (HIV)-associated dementia (HAD) progression, highlighting a pivotal role for astrocytes in HIV neuropathogenesis. Yet, astrocytes limit HIV, indicating that they posses an intrinsic molecular mechanism to restrict HIV replication. We previously established that this restriction can be partly overcome by priming astrocytes with gamma interferon (IFN-), which is elevated in the cerebral spinal fluid of HAD patients. We evaluated the mechanism of restrictive HIV replication in astrocytes and how IFN- priming modulates this restriction. We demonstrate that the downstream effector of Wnt signaling, T-cell factor 4 (TCF-4), is part of a transcriptional complex that is immunoprecipitated with HIV TAR-containing region in untreated astrocytes but not in IFN--treated cells. Blocking TCF-4 activity with a dominant-negative mutant enhanced HIV replication by threefold in both the astrocytoma cell line U87MG and primary fetal astrocytes. Using a TCF-4 reporter plasmid, we directly demonstrate that Wnt signaling is active in human astrocytes and is markedly reduced by IFN- treatment. Collectively, these data implicate TCF-4 in repressing HIV replication and the ability of IFN- to regulate this restriction by inhibiting TCF-4. Given that TCF-4 is the downstream effector of Wnt signaling, harnessing Wnt signaling as an intrinsic molecular mechanism to limit HIV replication may emerge as a powerful tool to regulate HIV replication within and outside of the brain.

---

* Corresponding author. Mailing address: Rush University Medical Center, Department of Immunology/Microbiology, 1735 W. Harrison Street, 614 Cohn, Chicago, IL 60612. Phone: (312) 563-3220. Fax: (312) 942-2808. E-mail: lalharth{at}rush.edu

Published ahead of print on 28 March 2007.

---

Journal of Virology, June 2007, p. 5864-5871, Vol. 81, No. 11
0022-538X/07/$08.00+0     doi:10.1128/JVI.02234-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Kumar, A., Zloza, A., Moon, R. T., Watts, J., Tenorio, A. R., Al-Harthi, L. (2008). Active {beta}-Catenin Signaling Is an Inhibitory Pathway for Human Immunodeficiency Virus Replication in Peripheral Blood Mononuclear Cells. J. Virol. 82: 2813-2820 [Abstract] [Full Text]